Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-fluorouracil after radiotherapy in relapsed/refractory ependymoma
2014-001470-34Phase 2Unknown
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil in ependymoma, sponsored by Royal Marsden NHS Foundation Trust. Primary endpoint: Overall response rate after 6 cycles. Status: unknown.
02
Drugs
fluorouracil
03
Conditions
ependymoma
Beyond the preview
Go deeper on 2014-001470-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001470-34.